结构性附着点病变与银屑病进展为银屑病关节炎风险增加相关
该前瞻性队列研究纳入114例无临床肌肉骨骼受累的银屑病患者,基线采用高分辨率外周定量CT评估结构性附着点病变和附着点及关节内体积骨密度(vBMD)。中位随访28.2±17.7个月期间24例进展为银屑病关节炎(PsA),结构性附着点病变者进展风险显著升高(HR 5.10,95%CI 1.53-16.99,P=0.008),附着点皮质vBMD较高与进展风险降低相关。
要点
- 结构性附着点病变的银屑病患者进展为PsA风险显著升高(HR 5.10)。
- 附着点皮质vBMD每增加1个标准差,PsA进展风险降低(HR 0.32)。
- 附着点vBMD而非关节内vBMD与PsA进展风险降低相关。
核心结论
- 结构性附着点病变及附着点皮质vBMD较低与银屑病患者进展为PsA风险增加相关。
研究设计与样本
- 前瞻性队列研究,纳入114例无临床肌肉骨骼受累的银屑病患者(72男42女),基线采用高分辨率外周定量CT评估结构性附着点病变和vBMD。
- 平均随访28.2±17.7个月,采用多变量Cox回归模型计算调整后相对风险。
主要发现
- 随访期间24例患者进展为PsA,发病率为9.7/100患者年(95%CI 6.2-14.5)。
- 有结构性附着点病变者PsA发病率21.4/100患者年(95%CI 12.5-34.3),HR 5.10(95%CI 1.53-16.99),P=0.008。
- 附着点vBMD每增加1个标准差与PsA进展风险降低约30%相关。
- 附着点皮质vBMD较高与PsA风险降低相关(HR 0.32/1 SD,95%CI 0.14-0.71),多重插补后仍稳健(HR 0.64,95%CI 0.42-0.98)。
临床怎么用
- 对无临床肌肉骨骼受累的银屑病患者,可考虑基线评估结构性附着点病变及附着点皮质vBMD以识别PsA高风险人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test whether the presence of structural entheseal lesions in psoriasis patients influences the risk of progression to psoriatic arthritis (PsA). METHODS: We conducted a prospective cohort study of psoriasis patients without clinical evidence of musculoskeletal involvement who underwent baseline assessment of structural entheseal lesions and volumetric bone mineral density (vBMD) at entheseal and intraarticular sites by high-resolution peripheral quantitative computed tomography. Adjusted relative risks of developing PsA associated with baseline vBMD and the presence of structural entheseal lesions were calculated using multivariable Cox regression models. RESULTS: The cohort included 114 psoriasis patients (72 men and 42 women) with a mean ± SD follow-up duration of 28.2 ± 17.7 months, during which 24 patients developed PsA (9.7 per 100 patient-years [95% confidence interval (95% CI) 6.2-14.5]). Patients with structural entheseal lesions were at higher risk of developing PsA compared to patients without such lesions (21.4 per 100 patient-years [95% CI 12.5-34.3]; hazard ratio [HR] 5.10 [95% CI 1.53-16.99], P = 0.008). With respect to vBMD, a 1-SD increase in entheseal, but not intraarticular, vBMD was associated with an ~30% reduced risk of progression to PsA. Especially, higher cortical vBMD at entheseal segments was associated with a lower risk of developing PsA (HR 0.32 per 1 SD [95% CI 0.14-0.71]), and the association remained robust after multiple imputation of missing data (HR 0.64 [95% CI 0.42-0.98]). CONCLUSION: The presence of structural entheseal lesions as well as low cortical vBMD at entheseal segments are associated with an increased risk of developing PsA in patients with psoriasis.
引用
- Simon D, Tascilar K, Kleyer A, et al. Association of Structural Entheseal Lesions With an Increased Risk of Progression From Psoriasis to Psoriatic Arthritis. Arthritis Rheumatol. 2021. PMID: 32103639. doi:10.1002/art.41239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。